Skip to main content
Fordel Studios logoFordel Studios
Start a Conversation
Back to Pulse
TechCrunch

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

Read the full articleFrom OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development on TechCrunch
↗

What Happened

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Our Take

Look, drug discovery's the sexiest AI narrative right now — faster trials, better candidates, fewer failures. Chai Discovery caught the wave.

But the real move isn't the product; it's the Eli Lilly data partnership. Pharma data is worth billions. This is institutional validation that AI can move R&D timelines.

(Though 'we'll make drugs cheaper' still hits every regulatory wall we haven't figured out yet.)

What To Do

If Eli Lilly publishes efficacy wins tied to Chai's platform in 18 months, the healthcare AI thesis is real; if not, it's just an expensive hire.

Cited By

React

Loading comments...